Acquisition of Emerald Health Therapeutics, Inc - Estimated Incurred Costs (Details) - Emerald Health Therapeutics Inc |
Nov. 10, 2022
USD ($)
|
|---|---|
| Asset Acquisition [Line Items] | |
| Quarter one | $ 315,400 |
| Thereafter | 170,500 |
| Total future estimated costs: | $ 485,900 |
| X | ||||||||||
- Definition Asset Acquisition, Wind-Down Costs To Be Paid No definition available.
|
| X | ||||||||||
- Definition Asset Acquisition, Wind-Down Costs To Be Paid, Quarter One No definition available.
|
| X | ||||||||||
- Definition Asset Acquisition, Wind-Down Costs To Be Paid, Thereafter No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|